Stay updated on Pralsetinib vs Standard of Care in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 has been added; the notices about a lapse in government funding and Revision: v3.4.1 have been removed. These are minor site maintenance changes and do not affect study content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T14:38:51.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    A global site notice about government funding and NIH operations was added, and the page revision was updated from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T10:41:10.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    UI/metadata updates: glossary toggle added, a new 'Last Update Submitted that Met QC Criteria' label, and a revision indicator (v3.4.0); the prior lowercase QC label ('Last Update Submitted that met QC Criteria'), 'No FEAR Act data' wording, and older revision text (v3.3.4) were removed.
    Difference
    0.1%
    Check dated 2026-01-28T06:27:21.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.3.4, replacing Revision: v3.3.3.
    Difference
    0.0%
    Check dated 2026-01-14T03:11:27.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    The page now displays 'Results Submitted' instead of 'No Results Posted'. This indicates that study results have been submitted for the record.
    Difference
    0.0%
    Check dated 2026-01-07T01:29:37.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Locations sections were updated to add sites in New South Wales, Rio Grande do Sul, São Paulo, Abruzzo, Campania, Emilia-Romagna, Lazio, Tuscany, Veneto, Mexico City, Barcelona, Cantabria, and La Coruña, while several other locations were removed.
    Difference
    0.8%
    Check dated 2025-12-23T22:41:18.000Z thumbnail image

Stay in the know with updates to Pralsetinib vs Standard of Care in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.